Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer
22nd Nov 2005, 20:32 GMT
Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer related news:
- Prostate size matters say US scientists — HEALTH
- Smaller prostate size, more aggressive cancer — Health News Online - Medical and health information and tools from Armenian Medical Network
- Australian prostate cancer drug shows promise — KeralaNext: Science
- Daily pill may beat prostate cancer — HEALTH
- Three months’ treatment with the α1-blocker alfuzosin does not affect total or transition zone volume of the prostate — Prostate Cancer and Prostatic Diseases
- Novel gene silencing therapy for cervical cancer — KeralaNext: Health
- Endorectal coil improves prostate cancer detection — EurekAlert! - Breaking News
- Omega-3 fatty acids and cancer — The Cancer Blog
- Sales of Major Players in the Prostrate Cancer Market have been Eroded by the Launch of Various LHRH Agonist Depot Formulations — PR Web (The Free Wire Service) Medical Cancer
- New approach for the treatment of cervical cancer - New gene silencing therapy — Medical News Today RSS/XML Feed